Hearing aid use linked to better cognition in hearing-impaired elderly

  • A study of older adults with impaired hearing supports the use of hearing aids to help fight the development of cognitive decline and dementia.

A study involving 100 older adults (aged 80-99) with hearing loss has found that those who used a hearing aid performed significantly better on a cognitive test (MMSE) than those who didn't use a hearing aid, despite having poorer hearing. Among non-users, participants with more hearing loss had lower MMSE scores than those with better hearing.

In the MMSE, participants give vocal responses to verbal commands. Executive function was also assessed with the Trail Making Test, Part B, which doesn't have a verbal or auditory component. On this test, although hearing aid users performed better than non-users, the difference was not statistically significant. Nor were scores correlated with hearing level.

The finding suggests that hearing loss is associated with sensory-specific cognitive decline rather than global cognitive impairment.

Of the 100 participants, 34 regularly used a hearing aid.

Previous studies have found hearing loss is associated with greater cognitive decline in older adults. A physician recently told the annual meeting of the American Association for the Advancement of Science (AAAS) that as much as 36% of dementia risk might be attributable to hearing impairment, and urged that doctors treat age-related hearing impairment more seriously.

The finding supports the view that use of hearing aids for the hearing impaired may help keep them more socially engaged, thus preventing or slowing the progression of cognitive decline and the development of dementia.

More than half of adults over age 75 have hearing loss, yet less than 15% of the hearing impaired use a hearing aid.

http://www.eurekalert.org/pub_releases/2016-04/cumc-hau042216.php

Reference: 

Related News

A survey of 7,072 older adults in six provinces across China, with one rural and one urban community in each province, has identified 359 older adults with dementia and 328 with depression.

A survey of 7796 older adults (65+) living in three geographic areas in England has allowed us to compare dementia rates over time, with an identical survey having been taken between 1989 and 1994. The overall prevalence of dementia fell significantly, from 8.3% to 6.5%.

A large Danish study comparing two groups of nonagenarians born 10 years apart has found that not only were people born in 1915 nearly a third (32%) more likely to reach the age of 95 than those in the 1905 cohort, but members of the group born in 1915 performed significantly better on tests of

A five-year study involving 525 older adults (70+) found 46 had Alzheimer’s or aMCI and a further 28 went on to develop the conditions.

A three-year study involving 152 adults aged 50 and older, of whom 52 had been recently diagnosed with mild cognitive impairment and 31 were diagnosed with Alzheimer's disease, has found that those with mild or no cognitive impairment who initially had amyloid-beta plaques showed greater cogniti

More evidence for early changes in the eye in Alzheimer’s disease comes from a study involving both rats and postmortem human retinas.

Blocking a receptor involved in inflammation in the brains of mice with severe Alzheimer’s produced marked recovery in blood flow and vascular reactivity, a dramatic reduction in toxic amyloid-beta, and significant improvements in learning and memory.

A multi-year study involving 207 healthy older adults, in which their spinal fluids were repeatedly sampled and their brains repeatedly scanned, has found that disruptions in the default mode network emerges about the same time as chemical markers of Alzheimer’s appear in the spinal fluid (decre

An analysis of the anatomical connectivity in the brains of 15 people with Alzheimer's disease, 68 with mild cognitive impairment and 28 healthy older individuals, has found several measures showed disease effects:

The first detailed characterization of the molecular structures of amyloid-beta fibrils that develop in the brains of those with Alzheimer's disease suggests that different molecular structures of amyloid-beta fibrils may distinguish the brains of Alzheimer's patients with different clinical his

Pages

Subscribe to Latest newsSubscribe to Latest newsSubscribe to Latest health news